Cell transformation by Herpesvirus saimiri

Journal of Cellular Physiology

Volumn 203, Issue 2, 2005, Pages 305-318

  Tsygankov, Alexander Y ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE LCK; RNA; STAT1 PROTEIN; STAT3 PROTEIN; STP PROTEIN; STPA PROTEIN; STPB PROTEIN; STPC PROTEIN; T LYMPHOCYTE RECEPTOR; TIP PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; EXPERIMENTAL MODEL; HERPES VIRUS; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; STRAIN DIFFERENCE; T LYMPHOCYTE; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 2, SAIMIRIINE; HIV-1; HUMANS; LYMPHOMA, T-CELL; MODELS, BIOLOGICAL; ONCOGENE PROTEINS, VIRAL; TUMOR VIRUS INFECTIONS;

HERPESVIRIDAE; HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; RHADINOVIRUS; SAIMIRI; SAIMIRIINE HERPESVIRUS 2;

EID: 16344377458     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20225     Document Type: Review

References (194)

1. Ahuja SK, Murphy PM. 1993. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J Biol Chem 268(28):20691-20694.
2. Albrecht JC, Nicholas J, Biller D, Cameron KR, Biesinger B, Newman C, Wittmann S, Craxton MA, Coleman H, Fleckenstein B, et al. 1992. Primary structure of the herpesvirus saimiri genome. J Virol 66(8):5047-5058.
3. Alexander L, Du Z, Rosenzweig M, Jung JU, Desrosiers RC. 1997. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol 71(8):6094-6099.
4. Alexandropoulos K, Baltimore D. 1996. Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin. Genes Dev 10(11):1341-1355.
5. Allende LM, Hernandez M, Corell A, Garcia-Perez MA, Varela P, Moreno A, Caragol I, Garcia-Martin F, Guillen-Perales J, Olive T, Espanol T, Arnaiz-Villena A. 2000. A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: A possible CD2/lymphocyte function-associated antigen-1 functional association in humans. Immunology 99(3):440-450.
6. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL. 1998. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280(5368):1432-1435.
7. Alvarez-Zapata D, de Miguel Olalla S, Fontan G, Ferreira A, Garcia-Rodriguez MC, Madero L, van den Elsen P, Regueiro JR. 1998. Phenotypical and functional characterization of Herpesvirus saimiri-immortalized human major histocompatibility complex class II-deficient T lymphocytes. Tissue Antigens 51(3):250-257.
8. Bachi A, Braun IC, Rodrigues JP, Pante N, Ribbeck K, von Kobbe C, Kutay U, Wilm M, Gorlich D, Carmo-Fonseca M, Izaurralde E. 2000. The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates. RNA 6(1):136-158.
9. Baldari CT, Heguy A, Telford JL. 1993. Calcium-dependent cyclosporin-A-sensitive activation of the interleukin-2 promoter by p56(lck). J Biol Chem 268(12):8406-8409.
10. Ballestas ME, Chatis PA, Kaye KM. 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284(5414):641-644.
11. Biesinger B, Trimble JJ, Desrosiers RC, Fleckenstein B. 1990. The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology 176(2):505-514.
12. Biesinger B, Muller-Fleckenstein I, Simmer B, Lang G, Wittmann S, Platzer E, Desrosiers RC, Fleckenstein B. 1992. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci USA 89(7):3116-3119.
13. Biesinger B, Tsygankov AY, Fickenscher H, Emmrich F, Fleckenstein B, Bolen JB, Broker BM. 1995. The product of the Herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p56lck in transformed cells. J Biol Chem 270(9):4729-4734.
14. Braun IC, Herold A, Rode M, Conti E, Izaurralde E. 2001. Overexpression of TAP/p15 heterodimers bypasses nuclear retention and stimulates nuclear mRNA export. J Biol Chem 276(23):20536-20543.
15. Braun IC, Herold A, Rode M, Izaurralde E. 2002. Nuclear export of mRNA by TAP/NXF1 requires two nucleoporin-binding sites but not p15. Mol Cell Biol 22(15):5405-5418.
16. Briggs SD, Sharkey M, Stevenson M, Smithgall TE. 1997. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J Biol Chem 272(29):17899-17902.
17. Broker BM, Fickenscher H. 1999. Herpesvirus saimiri strategies for T cell stimulation and transformation [review]. Med Microbiol Immunol 187(3):127-136.
18. Broker BM, Kraft MS, Klauenberg U, Le Deist F, de Villartay JP, Fleckenstein B, Fleischer B, Meinl E. 1997. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1). Eur J Immunol 27(11):2774-2780.
19. Cahir McFarland ED, Izumi KM, Mosialos G. 1999. Epstein-Barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 18(49):6959-6964.
20. Calderwood MA, Hall KT, Matthews DA, Whitehouse A. 2004a. The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. J Gen Virol 85(Pt 1):147-153.
21. Calderwood MA, White RE, Whitehouse A. 2004b. Development of herpesvirus-based episomally maintained gene delivery vectors. Expert Opin Biol Ther 4(4):493-505.
22. Choi JK, Ishido S, Jung JU. 2000. The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity. J Virol 74(17):8102-8110.
23. Chung YH, Cho NH, Garcia MI, Lee SH, Feng P, Jung JU. 2004. Activation of Stat3 transcription factor by Herpesvirus saimiri STP-A oncoprotein. J Virol 78(12):6489-6497.
24. Collins CM, Medveczky MM, Lund T, Medveczky PG. 2002. The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome. J Gen Virol 83(Pt 9):2269-2278.
25. Cooper M, Goodwin DJ, Hall KT, Stevenson AJ, Meredith DM, Markham AF, Whitehouse A. 1999. The gene product encoded by ORF 57 of herpesvirus saimiri regulates the redistribution of the splicing factor SC-35. J Gen Virol 80(Pt 5):1311-1316.
26. Copeland KF, McKay PJ, Rosenthal KL. 1996. Suppression of the human immunodeficiency virus long terminal repeat by CD8+ T cells is dependent on the NFAT-1 element. AIDS Res Hum Retroviruses 12(2):143-148.
27. Coscoy L, Gonzalez-Dunia D, Tangy F, Syan S, Brahic M, Ozden S. 1998. Molecular mechanism of tumorigenesis in mice transgenic for the human T cell leukemia virus Tax gene. Virology 248(2):332-341.
28. Cotter MA II, Robertson ES. 1999. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264(2):254-264.
29. Coultas L, Strasser A. 2003. The role of the Bcl-2 protein family in cancer. Semin Cancer Biol 13(2):115-123.
30. Cullen BR. 2003. Nuclear mRNA export: Insights from virology. Trends Biochem Sci 28(8):419-424.
31. Damania B, Jung JU. 2001. Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and herpesvirus saimiri. Adv Cancer Res 80:51-82.
32. Damania B, Lee H, Jung JU. 1999. Primate herpesviral oncogenes. Mol Cells 9(4):345-349.
33. Damania B, Choi JK, Jung JU. 2000. Signaling activities of gammaherpesvirus membrane proteins. J Virol 74(4):1593-1601.
34. De Carli M, Berthold S, Fickenscher H, Fleckenstein IM, D'Elios MM, Gao Q, Biagiotti R, Giudizi MG, Kalden JR, Fleckenstein B, et al. 1993. Immortalization with herpesvirus saimiri modulates the cytokine secretion profile of established Th1 and Th2 human T cell clones. J Immunol 151(9):5022-5030.
35. Denny MF, Patai B, Straus DB. 2000. Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn. Mol Cell Biol 20(4):1426-1435.
36. Derfuss T, Fickenscher H, Kraft MS, Henning G, Lengenfelder D, Fleckenstein B, Meinl E. 1998. Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: Stabilization of mitochondria and inhibition of caspase-3-like activity. J Virol 72(7):5897-5904.
37. Desrosiers RC, Falk LA. 1982. Herpesvirus saimiri strain variability. J Virol 43(1):352-356.
38. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kappaB activation. Mol Cell Biol 16(12):7098-7108.
39. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. 1998. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72(10):8309-8315.
40. Duboise M, Guo J, Czajak S, Lee H, Veazey R, Desrosiers RC, Jung JU. 1998a. A role for herpesvirus saimiri orf14 in transformation and persistent infection. J Virol 72(8):6770-6776.
41. Duboise SM, Guo J, Czajak S, Desrosiers RC, Jung JU. 1998b. STP and Tip are essential for herpesvirus saimiri oncogenicity. J Virol 72(2):1308-1313.
42. Duboise SM, Lee H, Guo J, Choi JK, Czajak S, Simon M, Desrosiers RC, Jung JU. 1998c. Mutation of the Lck-binding motif of Tip enhances lymphoid cell activation by herpesvirus saimiri. J Virol 72(4):2607-2614.
43. Ensser A, Pfinder A, Muller-Fleckenstein I, Fleckenstein B. 1999. The URNA genes of herpesvirus saimiri (strain C488) are dispensable for transformation of human T cells in vitro. J Virol 73(12):10551-10555.
44. Ensser A, Glykofrydes D, Niphuis H, Kuhn EM, Rosenwirth B, Heeney JL, Niedobitek G, Muller-Fleckenstein I, Fleckenstein B. 2001. Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J Exp Med 193(5):637-642.
45. Ensser A, Thurau M, Wittmann S, Fickenscher H. 2003. The genome of herpesvirus saimiri C488 which is capable of transforming human T cells. Virology 314(2):471-487.
46. Fickenscher H, Fleckenstein B. 2001. Herpesvirus saimiri. Philos Trans R Soc Lond B Biol Sci 356(1408):545-567.
47. Fickenscher H, Biesinger B, Knappe A, Wittmann S, Fleckenstein B. 1996. Regulation of the herpesvirus saimiri oncogene stpC, similar to that of T-cell activation genes, in growth-transformed human T lymphocytes. J Virol 70(9):6012-6019.
48. Fickenscher H, Bokel C, Knappe A, Biesinger B, Meinl E, Fleischer B, Fleckenstein B, Broker BM. 1997. Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus saimiri. J Virol 71(3):2252-2263.
49. Fleckenstein B, Desrosiers R. 1983. Herpesvirus saimiri and Herpesvirus ateles. In: Roizman B, editor. The Herpesviruses. NY: Plenum Press. pp 253-332.
50. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines [see comments]. Jpn J Exp Med 183(6):2593-2603.
51. Fowler P, Marques S, Simas JP, Efstathiou S. 2003. ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol 84(Pt 12):3405-3416.
52. Frolova-Jones EA, Ensser A, Stevenson AJ, Kinsey SE, Meredith DM. 2000. Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors. J Hematother Stem Cell Res 9(4):573-581.
53. Fujimuro M, Hayward SD. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J Virol 77(14):8019-8030.
54. Fujita M, Yoshida A, Sakurai A, Tatsuki J, Ueno F, Akari H, Adachi A. 2003. Susceptibility of HVS-immortalized lymphocytic HSC-F cells to various strains and mutants of HIV/SIV. Int J Mol Med 11(5):641-644.
55. Gallego MD, Santamaria M, Pena J, Molina IJ. 1997. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to Cd3-mediated stimulation. Blood 90(8):3089-3097.
56. Geffin R, Wolf D, Muller R, Hill MD, Stellwag E, Freitag M, Sass G, Scott GB, Baur AS. 2000. Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors. AIDS Res Hum Retroviruses 16(17):1855-1868.
57. Glykofrydes D, Niphuis H, Kuhn EM, Rosenwirth B, Heeney JL, Bruder J, Niedobitek G, Muller-Fleckenstein I, Fleckenstein B, Ensser A. 2000. Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. J Virol 74(24):11919-11927.
58. Goodwin DJ, Whitehouse A. 2001. A gamma-2 herpesvirus nucleocytoplasmic shuttle protein interacts with importin alpha 1 and alpha 5. J Biol Chem 276(23):19905-19912.
59. Goodwin DJ, Hall KT, Stevenson AJ, Markham AF, Whitehouse A. 1999. The open reading frame 57 gene product of herpesvirus saimiri shuttles between the nucleus and cytoplasm and is involved in viral RNA nuclear export. J Virol 73(12):10519-10524.
60. Goodwin DJ, Hall KT, Giles MS, Calderwood MA, Markham AF, Whitehouse A. 2000. The carboxy terminus of the herpesvirus saimiri ORF 57 gene contains domains that are required for transactivation and transrepression. J Gen Virol 81(Pt 9):2253-2265.
61. Goodwin DJ, Walters MS, Smith PG, Thurau M, Fickenscher H, Whitehouse A. 2001. Herpesvirus saimiri open reading frame 50 (Rta) protein reactivates the lytic replication cycle in a persistently infected A549 cell line. J Virol 75(8):4008-4013.
62. Greve T, Tamguney G, Fleischer B, Fickenscher H, Broker BM. 2001. Down-regulation of p56(lck) tyrosine kinase activity in T cells of squirrel monkeys (Saimiri sciureus) correlates with the nontransforming and apathogenic properties of herpesvirus saimiri in its natural host. J Virol 75(19):9252-9261.
63. Guo J, Duboise M, Lee H, Li M, Choi JK, Rosenzweig M, Jung JU. 1997. Enhanced downregulation of Lck-mediated signal transduction by a Y114 mutation of herpesvirus Saimiri tip. J Virol 71(9):7092-7096.
64. Guo J, Williams K, Duboise SM, Alexander L, Veazey R, Jung JU. 1998. Substitution of ras for the herpesvirus saimiri STP oncogene in lymphocyte transformation. J Virol 72(5):3698-3704.
65. Hall KT, Stevenson AJ, Goodwin DJ, Gibson PC, Markham AF, Whitehouse A. 1999. The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein. J Virol 73(12):9756-9763.
66. Hall KT, Giles MS, Goodwin DJ, Calderwood MA, Carr IM, Stevenson AJ, Markham AF, Whitehouse A. 2000a. Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri. J Virol 74(16):7331-7337.
67. Hall KT, Giles MS, Goodwin DJ, Calderwood MA, Markham AF, Whitehouse A. 2000b. Characterization of the herpesvirus saimiri ORF73 gene product. J Gen Virol 81 Pt 11:2653-2658.
68. Harada H, Grant S. 2003. Apoptosis regulators. Rev Clin Exp Hematol 7(2):117-138.
69. Hartley DA, Cooper GM. 2000. Direct binding and activation of STAT transcription factors by the herpesvirus saimiri protein tip. J Biol Chem 275(22):16925-16932.
70. Hartley DA, Hurley TR, Hardwick JS, Lund TC, Medveczky PG, Sefton BM. 1999. Activation of the lck tyrosine-protein kinase by the binding of the tip protein of herpesvirus saimiri in the absence of regulatory tyrosine phosphorylation. J Biol Chem 274(29):20056-20059.
71. Hartley DA, Amdjadi K, Hurley TR, Lund TC, Medveczky PG, Sefton BM. 2000. Activation of the Lck tyrosine protein kinase by the Herpesvirus saimiri tip protein involves two binding interactions. Virology 276(2):339-348.
72. Hasham MG, Tsygankov AY. 2004. Tip, an Lck-interacting protein of Herpesvirus saimiri, causes Fas- and Lck-dependent apoptosis of T lymphocytes. Virology 320(2):313-329.
73. He Z, Xin B, Yang X, Chan C, Cao L. 2000. Nuclear factor-kappaB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts. Cancer Res 60(7):1845-1848.
74. Henderson EE, Tsygankov AY, Merlo JJ, Romano G, Guan M. 1999. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and/or Tip. Virology 264(1):125-133.
75. Henning G, Kraft MS, Derfuss T, Pirzer R, de Saint-Basile G, Aversa G, Fleckenstein B, Meinl E. 2001. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity. Eur J Immunol 31(9):2741-2750.
76. Hiller C, Tamguney G, Stolte N, Matz-Rensing K, Lorenzen D, Hor S, Thurau M, Wittmann S, Slavin S, Fickenscher H. 2000a. Herpesvirus saimiri pathogenicity enhanced by thymidine kinase of herpes simplex virus. Virology 278(2):445-455.
77. Hiller C, Wittmann S, Slavin S, Fickenscher H. 2000b. Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector. Gene Ther 7(8):664-674.
78. Hiscott J, Kwon H, Genin P. 2001. Hostile takeovers: Viral appropriation of the NF-kappaB pathway. J Clin Invest 107(2):143-151.
79. Hor S, Ensser A, Reiss C, Ballmer-Hofer K, Biesinger B. 2001. Herpesvirus saimiri protein StpB associates with cellular Src. J Gen Virol 82(Pt 2):339-344.
80. Isakov N, Biesinger B. 2000. Lck protein tyrosine kinase is a key regulator of T-cell activation and a target for signal intervention by Herpesvirus saimiri and other viral gene products. Eur J Biochem 267(12):3413-3421.
81. Izumi KM, Kieff ED. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc Natl Acad Sci USA 94(23):12592-12597.
82. Jung JU, Desrosiers RC. 1991. Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488. J Virol 65(12):6953-6960.
83. Jung JU, Desrosiers RC. 1994. Distinct functional domains of STP-C488 of herpesvirus saimiri. Virology 204(2):751-758.
84. Jung JU, Desrosiers RC. 1995. Association of the viral oncoprotein STP-C488 with cellular ras. Mol Cell Biol 15(12):6506-6512.
85. Jung JU, Trimble JJ, King NW, Biesinger B, Fleckenstein BW, Desrosiers RC. 1991. Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. Proc Natl Acad Sci USA 88(16):7051-7055.
86. Jung JU, Stager M, Desrosiers RC. 1994. Virus-encoded cyclin. Mol Cell Biol 14(11):7235-7244.
87. Jung JU, Lang SM, Friedrich U, Jun T, Roberts TM, Desrosiers RC, Biesinger B. 1995a. Identification of Lck-binding elements in tip of herpesvirus saimiri. J Biol Chem 270(35):20660-20667.
88. Jung JU, Lang SM, Jun T, Roberts TM, Veillette A, Desrosiers RC. 1995b. Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri. J Virol 69(12):7814-7822.
89. Jung JU, Choi JK, Ensser A, Biesinger B. 1999. Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. Semin Cancer Biol 9(3):231-239.
90. Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G. 1996. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc Natl Acad Sci USA 93(20):11085-11090.
91. Kedes DH, Lagunoff M, Renne R, Ganem D. 1997. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100(10):2606-2610.
92. Kennedy J, Rossi DL, Zurawski SM, Vega F, Jr., Kastelein RA, Wagner JL, Hannum CH, Zlotnik A. 1996. Mouse IL-17: A cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells. J Interferon Cytokine Res 16(8):611-617.
93. Kjellen P, Amdjadi K, Lund TC, Medveczky PG, Sefton BM. 2002. The herpesvirus saimiri tip484 and tip488 proteins both stimulate lck tyrosine protein kinase activity in vivo and in vitro. Virology 297(2):281-288.
94. Knappe A, Hiller C, Thurau M, Wittmann S, Hofmann H, Fleckenstein B, Fickenscher H. 1997. The superantigen-homologous viral immediate-early gene Ie14/Vsag in herpesvirus saimiri-transformed human T cells. J Virol 71(12):9124-9133.
95. Knappe A, Hiller C, Niphuis H, Fossiez F, Thurau M, Wittmann S, Kuhn EM, Lebecque S, Banchereau J, Rosenwirth B, Fleckenstein B, Heeney J, Fickenscher H. 1998a. The interleukin-17 gene of herpesvirus saimiri. J Virol 72(7):5797-5801.
96. Knappe A, Thurau M, Niphuis H, Hiller C, Wittmann S, Kuhn EM, Rosenwirth B, Fleckenstein B, Heeney J, Fickenscher H. 1998b. T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homology. J Virol 72(4):3469-3471.
97. Knappe A, Feldmann G, Dittmer U, Meinl E, Nisslein T, Wittmann S, Matz-Rensing K, Kirchner T, Bodemer W, Fickenscher H. 2000. Herpesvirus saimiri-transformed macaque T cells are tolerated and do not cause lymphoma after autologous reinfusion. Blood 95(10):3256-3261.
98. Kraft MS, Henning G, Fickenscher H, Lengenfelder D, Tschopp J, Fleckenstein B, Meinl E. 1998. Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis. J Virol 72(4):3138-3145.
99. Kretschmer C, Murphy C, Biesinger B, Beckers J, Fickenscher H, Kirchner T, Fleckenstein B, Ruther U. 1996. A Herpes saimiri oncogene causing peripheral T-cell lymphoma in transgenic mice. Oncogene 12(8):1609-1616.
100. Lacey SF, Weinhold KJ, Chen CH, McDanal C, Oei C, Greenberg ML. 1998. Herpesvirus saimiri transformation of HIV type 1 suppressive CD8+ lymphocytes from an HIV type 1-infected asymptomatic individual. AIDS Res Hum Retroviruses 14(6):521-531.
101. Laman H, Coverley D, Krude T, Laskey R, Jones N. 2001. Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication. Mol Cell Biol 21(2):624-635.
102. Lee H, Trimble JJ, Yoon DW, Regier D, Desrosiers RC, Jung JU. 1997. Genetic variation of herpesvirus saimiri subgroup A transforming protein and its association with cellular src. J Virol 71(5):3817-3825.
103. Lee H, Choi JK, Li M, Kaye K, Kieff E, Jung JU. 1999. Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus saimiri STP. J Virol 73(5):3913-3919.
104. Lee SH, Chung YH, Cho NH, Gwack Y, Feng P, Jung JU. 2004. Modulation of T-cell receptor signal transduction by herpesvirus signaling adaptor protein. Mol Cell Biol 24(12):5369-5382.
105. Leight ER, Sugden B. 2000. EBNA-1: A protein pivotal to latent infection by Epstein-Barr virus. Rev Med Virol 10(2):83-100.
106. Li XH, Gaynor RB. 2000. Mechanisms of NF-kappaB activation by the HTLV type 1 tax protein. AIDS Res Hum Retroviruses 16(16):1583-1590.
107. Lukac DM, Renne R, Kirshner JR, Ganem D. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252(2):304-312.
108. Lund T, Medveczky MM, Neame PJ, Medveczky PG. 1996. A herpesvirus saimiri membrane protein required for interleukin-2 independence forms a stable complex with p56lck. J Virol 70(1):600-606.
109. Lund T, Medveczky M, Medveczky P. 1997a. Herpesvirus saimiri Tip-484 membrane protein markedly increases p56lck actvity in T cells. J Virol 71(1):378-382.
110. Lund TC, Garcia R, Medveczky MM, Jove R, Medveczky PG. 1997b. Activation of STAT transcription factors by Herpesvirus Saimiri Tip-484 requires p56lck. J Virol 71(9):6677-6682.
111. Lund TC, Prator PC, Medveczky MM, Medveczky PG. 1999. The Lck binding domain of herpesvirus saimiri Tip-484 constitutively activates Lck and STAT3 in T cells. J Virol 73(2):1689-1694.
112. Mackewicz CE, Orque R, Jung J, Levy JA. 1997. Derivation of herpesvirus saimiri-transformed Cd8+ T cell lines with noncytotoxic anti-HIV activity. Clin Immunol Immunopathol 82(3):274-281.
113. Martin-Villa JM, Ferre-Lopez S, Lopez-Suarez JC, Perez-Blas M, Castellano-Tortajada G, Sanchez-Gomez F, Arnaiz-Villena A. 1998. Successful in vitro immortalization of human intestinal mucosal lymphocytes with Herpesvirus saimiri. Tissue Antigens 52(5):430-434.
114. Matsumoto K, Shibata H, Fujisawa JT, Inoue H, Hakura A, Tsukahara T, Fujii M. 1997. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J Virol 71(6):4445-4451.
115. Medveczky P, Szomolanyi E, Desrosiers RC, Mulder C. 1984. Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol 52(3):938-944.
116. Medveczky MM, Szomolanyi E, Hesselton R, DeGrand D, Geck P, Medveczky PG. 1989. Herpesvirus saimiri strains from three DNA subgroups have different oncogenic potentials in New Zealand white rabbits. J Virol 63(9):3601-3611.
117. Medveczky MM, Geck P, Sullivan JL, Serbousek D, Djeu JY, Medveczky PG. 1993. IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus. Virology 196(2):402-412.
118. Meinl E, Hohlfeld R. 2000. T cell transformation with Herpesvirus saimiri: A tool for neuroimmunological research. J Neuroimmunol 103(1):1-7.
119. Meinl E, Derfuss T, Pirzer R, Blank N, Lengenfelder D, Blancher A, Le Deist F, Fleckenstein B, Hivroz C. 2001. Herpesvirus saimiri replaces ZAP-70 for CD3- and CD2-mediated T cell activation. J Biol Chem 276(40):36902-36908.
120. Melendez LV, Daniel MD, Hunt RD, Garcia FG. 1968. An apparently new herpesvirus from primary kidney cultures of the squirrel monkey (Saimiri sciureus). Lab Anim Care 18(3):374-381.
121. Merlo JJ, Tsygankov AY. 2001. Herpesvirus saimiri oncoproteins Tip and StpC synergistically stimulate NF-kappaB activity and interleukin-2 gene expression. Virology 279(1):325-338.
122. Merlo JJ, Romano G, Gordon SS, Feshchenko EA, Peng G, Henderson EE, Tsygankov AY. 1998. Human T cells transduced by a retroviral vector to express Herpesvirus saimiri proteins TIP and STPC. Anticancer Research 18(4A):2389-2396.
123. Mittrucker HW, Muller-Fleckenstein I, Fleckenstein B, Fleischer B. 1992. CD2-mediated autocrine growth of herpes virus saimiri-transformed human T lymphocytes. Jpn J Exp Med 176(3):909-913.
124. Mittrucker HW, Muller-Fleckenstein I, Fleckenstein B, Fleischer B. 1993. Herpes virus saimiri-transformed human T lymphocytes: Normal functional phenotype and preserved T cell receptor signalling. Int Immunol 5(8):985-990.
125. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, Miller WT. 1997. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385(6617):650-653.
126. Moorman NJ, Willer DO, Speck SH. 2003. The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol 77(19):10295-10303.
127. Mosoian A, Teixeira A, Caron E, Piwoz J, Klotman ME. 2000. CD8+ cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines. Viral Immunol 13(4):481-495.
128. Murphy C, Kretschmer C, Biesinger B, Beckers J, Jung J, Desrosiers RC, Muller-Hermelink HK, Fleckenstein BW, Ruther U. 1994. Epithelial tumours induced by a herpesvirus oncogene in transgenic mice. Oncogene 9(1):221-226.
129. Murthy SC, Trimble JJ, Desrosiers RC. 1989. Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J Virol 63(8):3307-3314.
130. Nakamura H, Zarycki J, Sullivan JL, Jung JU. 2001. Abnormal T cell receptor signal transduction of CD4 TH cells in X-linked lymphoproliferative syndrome. J Immunol 167(5):2657-2665.
131. Nava VE, Cheng EH, Veliuona M, Zou S, Clem RJ, Mayer ML, Hardwick JM. 1997. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol 71(5):4118-4122.
132. Nicholas J, Smith EP, Coles L, Honess R. 1990. Gene expression in cells infected with gammaherpesvirus saimiri: Properties of transcripts from two immediate-early genes. Virology 179(1):189-200.
133. Nicholas J, Coles LS, Newman C, Honess RW. 1991. Regulation of the herpesvirus saimiri (HVS) delayed-early 110-kilodalton promoter by HVS immediate-early gene products and a homolog of the Epstein-Barr virus R trans activator. J Virol 65(5):2457-2466.
134. Nick S, Fickenscher H, Biesinger B, Born G, Jahn G, Fleckenstein B. 1993. Herpesvirus saimiri transformed human T cell lines: A permissive system for human immunodeficiency viruses. Virology 194(2):875-877.
135. Okada K, Yasumura S, Muller-Fleckenstein I, Fleckenstein B, Talib S, Koldovsky U, Whiteside TL. 1997. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck. Cell Immunol 177(1):35-48.
136. Paca RE, Ogert HA, Hibbert CS, Izaurralde E, Beemon KL. 2000. Rous sarcoma virus DR posttranscriptional elements use a novel RNA export pathway. J Virol 74(20):9507-9514.
137. Pacheco-Castro A, Alvarez-Zapata D, Serrano-Torres P, Regueiro JR. 1998. Signaling through a CD3 gamma-deficient TCR/CD3 complex in immortalized mature CD4+ and CD8+ T lymphocytes. J Immunol 161(6):3152-3160.
138. Park J, Lee BS, Choi JK, Means RE, Choe J, Jung JU. 2002. Herpesviral protein targets a cellular WD repeat endosomal protein to downregulate T lymphocyte receptor expression. Immunity 17(2):221-233.
139. Park J, Cho NH, Choi JK, Feng P, Choe J, Jung JU. 2003. Distinct roles of cellular Lck and p80 proteins in herpesvirus saimiri Tip function on lipid rafts. J Virol 77(16):9041-9051.
140. Park J, Seo T, Jung J, Choe J. 2004. Herpesvirus saimiri STP A11 protein interacts with STAT3 and stimulates its transcriptional activity. Biochem Biophys Res Commun 320(1):279-285.
141. Pecher G, Harnack U, Gunther M, Hummel M, Fichtner I, Schenk JA. 2001. Generation of an immortalized human CD4+ T cell clone inhibiting tumor growth in mice. Biochem Biophys Res Commun 283(4):738-742.
142. Pon RA, Freedman MS. 2003. Study of Herpesvirus saimiri immortalization of gammadelta T cells derived from peripheral blood and CSF of multiple sclerosis patients. J Neuroimmunol 139(1-2):119-132.
143. Rao N, Miyake S, Reddi AL, Douillard P, Ghosh AK, Dodge IL, Zhou P, Fernandes ND, Band H. 2002. Negative regulation of Lck by Cbl ubiquitin ligase. Proc Natl Acad Sci USA 99(6):3794-3799.
144. Raymond AD, Hasham MG, Tsygankov AY, Henderson EE. 2004. Herpesvirus saimiri-encoded proteins Tip and StpC modulate human immunodeficiency virus type 1 replication in T-cell lines and lymphocytes independently of viral tropism. Virology 324(1):60-66.
145. Rivero-Carmena M, Porras O, Pelaez B, Pacheco-Castro A, Gatti RA, Regueiro JR. 2000. Membrane and transmembrane signaling in Herpesvirus saimiri-transformed human CD4(+) and CD8(+) T lymphocytes is ATM-independent. Int Immunol 12(6):927-935.
146. Robek MD, Ratner L. 1999. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J Virol 73(6):4856-4865.
147. Rodriguezgallego C, Corell A, Pacheco A, Timon M, Regueiro JR, Allende LM, Madrono A, Arnaizvillena A. 1996. Herpes virus saimiri transformation of T cells in Cd3-gamma immunodeficiency-phenotypic and functional characterization. J Immunol Methods 198(2):177-186.
148. Saadawi AM, L'Faqihi F, Diab BY, Sol MA, Enault G, Coppin H, Cantagrel A, Biesinger B, Fleckenstein B, Thomsen M. 1997. Dominant clones in immortalized T-cell lines from rheumatoid arthritis synovial membranes. Tissue Antigens 49(5):431-437.
149. Saha K, Caruso M, Volsky DJ. 1997. Human immunodeficiency virus type 1 (HIV-1) infection of herpesvirus saimiri-immortalized human CD4-positive T lymphoblastoid cells: Evidence of enhanced HIV-1 replication and cytopathic effects caused by endogenous interferon-gamma. Virology 231(1):1-9.
150. Saha K, Volsky DJ, Matczak E. 1999. Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: Evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry. J Virol 73(9):7891-7898.
151. Sarid R, Flore O, Bohenzky HA, Chang Y, Moore PS. 1998. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72(2):1005-1012.
152. Schafer A, Lengenfelder D, Grillhosl C, Wieser C, Fleckenstein B, Ensser A. 2003. The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J Virol 77(10):5911-5925.
153. Schulze-Gahmen U, Kim SH. 2002. Structural basis for CDK6 activation by a virus-encoded cyclin. Nat Struct Biol 9(3):177-181.
154. Schweimer K, Hoffmann S, Bauer F, Friedrich U, Kardinal C, Feller SM, Biesinger B, Sticht H. 2002. Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck. Biochemistry 41(16):5120-5130.
155. Smith PG, Coletta PL, Markham AF, Whitehouse A. 2001. In vivo episomal maintenance of a herpesvirus saimiri-based gene delivery vector. Gene Ther 8(23):1762-1769.
156. Sorokina EM, Merlo JJ, Jr., Tsygankov AY. 2004. Molecular mechanisms of the effect of Herpesvirus saimiri protein StpC on the signaling pathway leading to NF-{kappa}B activation. J Biol Chem 279(14):13469-13477.
157. Stephan V, Wahn V, Le Deist F, Dirksen U, Broker B, Muller-Fleckenstein I, Horneff G, Schroten H, Fischer A, de Saint Basile G. 1996. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med 335(21):1563-1567.
158. Stevenson AJ, Cooper M, Griffiths JC, Gibson PC, Whitehouse A, Jones EF, Markham AF, Kinsey SE, Meredith DM. 1999. Assessment of Herpesvirus saimiri as a potential human gene therapy vector. J Med Virol 57(3):269-277.
159. Stevenson AJ, Clarke D, Meredith DM, Kinsey SE, Whitehouse A, Bonifer C. 2000a. Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in vitro. Gene Ther 7(6):464-471.
160. Stevenson AJ, Frolova-Jones E, Hall KT, Kinsey SE, Markham AF, Whitehouse A, Meredith DM. 2000b. A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy. Cancer Gene Ther 7(7):1077-1085.
161. Straus DB, Weiss A. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70(4):585-593.
162. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 95(18):10866-10871.
163. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. 1997. Herpes viral cyclin/Cdk6 complexes evade inhibition by Cdk inhibitor proteins. Nature 390(6656):184-187.
164. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386(6624):517-521.
165. Thurau M, Whitehouse A, Wittmann S, Meredith D, Fickenscher H. 2000. Distinct transcriptional and functional properties of the R transactivator gene orf50 of the transforming herpesvirus saimiri strain C488. Virology 268(1):167-177.
166. Trimble JJ, Desrosiers RC. 1991. Transformation by herpesvirus saimiri. Adv Cancer Res 56:335-355.
167. Tsygankov AY. 2003. Non-receptor protein tyrosine kinases. Front Biosci 8:s595-s635.
168. Tsygankov AY, Romano G. 1999. Mechanisms of cell transformation by Herpesvirus saimiri. Anticancer Res 19(2A):973-983.
169. Valeri AP, Perez-Blas M, Gutierrez A, Lopez-Santalla M, Aguilera N, Rodriguez-Juan C, Sala-Silveira L, Martin J, Lasa I, Muguerza JM, Lopez A, Garcia-Sancho L, Granell J, Martin-Villa JM. 2003. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma. Cancer Immunol Immunother 52(11):708-714.
170. Vella C, Fickenscher H, Atkins C, Penny M, Daniels R. 1997. Herpesvirus saimiri-immortalized human T-cells support long-term, high titred replication of human immunodeficiency virus types 1 and 2. J Gen Virol 78(Pt 6):1405-1409.
171. Vella C, Gregory J, Bristow R, Troop M, Easterbrook P, Zheng N, Daniels R. 1999a. Isolation of HIV type 1 from long-term nonprogressors in Herpesvirus saimiri-immortalized T cells. AIDS Res Hum Retroviruses 15(12):1145-1147.
172. Vella C, Zheng NN, Vella G, Atkins C, Bristow RGW, Fickenscher H, Daniels RS. 1999b. Enhanced replication of M-tropic HIV-1 strains in Herpesvirus saimiri immortalised T-cells which express CCR5. J Virol Methods 79(1):51-63.
173. Vella C, Zheng NN, Easterbrook P, Daniels RS. 2002. Herpesvirus saimiri-immortalized human lymphocytes: Novel hosts for analyzing HIV type 1 in vitro neutralization. AIDS Res Hum Retroviruses 18(13):933-946.
174. Veri MC, DeBell KE, Seminario MC, DiBaldassarre A, Reischl I, Rawat R, Graham L, Noviello C, Rellahan BL, Miscia S, Wange RL, Bonvini E. 2001. Membrane raft-dependent regulation of phospholipase Cgamma-1 activation in T lymphocytes. Mol Cell Biol 21(20):6939-6950.
175. Verma SC, Robertson ES. 2003. ORF73 of herpesvirus Saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats. J Virol 77(23):12494-12506.
176. Wehner LE, Schroder N, Kamino K, Friedrich U, Biesinger B, Ruther U. 2001. Herpesvirus saimiri Tip gene causes T-cell lymphomas in transgenic mice. DNA Cell Biol 20(2):81-88.
177. Weis K. 2002. Nucleocytoplasmic transport: Cargo trafficking across the border. Curr Opin Cell Biol 14(3):328-335.
178. White RE, Calderwood MA, Whitehouse A. 2003. Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. J Gen Virol 84(Pt 12):3393-3403.
179. Whitehouse A. 2003. Herpesvirus saimiri: A potential gene delivery vector (review). Int J Mol Med 11(2):139-148.
180. Whitehouse A, Carr IM, Griffiths JC, Meredith DM. 1997a. The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases. J Virol 71(3):2550-2554.
181. Whitehouse A, Stevenson AJ, Cooper M, Meredith DM. 1997b. Identification of a cis-acting element within the herpesvirus saimiri ORF 6 promoter that is responsive to the HVS.R transactivator. J Gen Virol 78(Pt 6):1411-1415.
182. Whitehouse A, Cooper M, Hall KT, Meredith DM. 1998a. The open reading frame (ORF) 50a gene product regulates ORF 57 gene expression in herpesvirus saimiri. J Virol 72(3):1967-1973.
183. Whitehouse A, Cooper M, Meredith DM. 1998b. The immediate-early gene product encoded by open reading frame 57 of herpesvirus saimiri modulates gene expression at a posttranscriptional level. J Virol 72(1):857-861.
184. Wiegand HL, Coburn GA, Zeng Y, Kang Y, Bogerd HP, Cullen BR. 2002. Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes. Mol Cell Biol 22(1):245-256.
185. Wiese N, Tsygankov AY, Klauenberg U, Bolen JB, Fleischer B, Broker BM. 1996. Selective activation of T cell kinase p56lck by Herpesvirus saimiri protein tip. J Biol Chem 271(2):847-852.
186. Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T, Hatanaka M. 1996. Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J 15(4):873-887.
187. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, Spriggs MK. 1995a. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3(6):811-821.
188. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. 1995b. Human IL-17: A novel cytokine derived from T cells. J Immunol 155(12):5483-5486.
189. Yao Z, Maraskovsky E, Spriggs MK, Cohen JI, Armitage RJ, Alderson MR. 1996. Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation. J Immunol 156(9):3260-3266.
190. Yoon DW, Lee H, Seol W, DeMaria M, Rosenzweig M, Jung JU. 1997. Tap: A novel cellular protein that interacts with tip of herpesvirus saimiri and induces lymphocyte aggregation. Immunity 6(5):571-582.
191. Yoshida M. 2001. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19:475-496.
192. Zalani S, Holley-Guthrie E, Kenney S. 1996. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci USA 93(17):9194-9199.
193. Zapata DA, Pacheco-Castro A, Torres PS, Ramiro AR, Jose ES, Alarcon B, Alibaud L, Rubin B, Toribio ML, Regueiro JR. 1999. Conformational and biochemical differences in the TCR·CD3 complex of CD8(+) versus CD4(+) mature lymphocytes revealed in the absence of CD3gamma. J Biol Chem 274(49):35119-35128.
194. Zheng NN, Vella C, Easterbrook PJ, Daniels RS. 2002. Selection following isolation of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and herpesvirus saimiri-transformed T cells is comparable. J Gen Virol 83(Pt 6):1343-1352.